Trials / NCT00004827
Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis Pigmentosa
Completed N/A Supplement / diet
- Sponsor
- Retina Foundation of the Southwest
- Treatment
- docosahexaenoic acid
- Gene
- Not stated
- Conditions
- Retinitis Pigmentosa
- Ages
- Any to no upper limit
- Enrollment
- 46 participants
- Started
- 1996-03
- Main results expected
- Not stated
- Results posted
- Not yet
- Record last updated
- 2015-03-25
What the study is testing
OBJECTIVES:
I. Evaluate the potential of nutritional docosahexaenoic acid (DHA) supplementation to normalize the level of DHA in red blood cells, and to retard the progression of visual function loss in patients with early stage X-linked retinitis pigmentosa.
Where it runs
No sites listed yet.